- Health
- By Laura Sinpetru
- December 21st, 2012
Tredaptive: Merck Drug Fails to Reduce Heart Disease Risks
Merck & Co Inc's study on Tredaptive “did not meet its primary endpoint,” company admits
Merck & Co Inc's study on Tredaptive “did not meet its primary endpoint,” company admits